Following the successful completion of its inaugural GMP (Good Manufacturing Practice) project, simAbs has launched a new GMP cleanroom facility in partnership with Sealantium Medical, the company’s newest neighbour and resident at Bioville.
simAbs is a Belgium-based biotechnology company specialising in the research, development, and Good Manufacturing Practice (GMP) manufacturing of antibodies.
Sealantium Medical is a biosurgery company focused on developing next-generation tissue sealants and hemostatic agents for surgical patients.
Located in Diepenbeek, Belgium, Bioville is a leading health and care incubator that offers state-of-the-art facilities and a collaborative ecosystem for life sciences companies, fostering innovation in biotech, medtech, and digital health.
The new facility will serve as a dedicated space for the production of advanced bio-therapeutics
The project marks another significant milestone in simAbs’ ongoing commitment to advancing biopharmaceutical manufacturing.
The new facility will serve as a dedicated space for the production of advanced bio-therapeutics, adhering to the highest standards of quality, safety, and innovation.
Since the project’s initiation, substantial progress has been made. The installation of the HVAC systems is currently underway, and key structural components such as airlocks, Material Airlocks (MAL), Personnel Airlocks (PAL), and gowning areas are beginning to take shape.
The state-of-the-art facility is poised to set a new benchmark in GMP excellence,
This progress underscores the collaborative efforts and technical precision of ABN Cleanroom Technology NV, whose construction team continues to demonstrate unwavering dedication and craftsmanship.
“We believe every successful project lays the foundation for the next big step,” a simAbs spokesperson stated. “This cleanroom is a pivotal step in our mission to foster cutting-edge bioprocessing capabilities, and it exemplifies what can be achieved through expert collaboration.”
The state-of-the-art facility is poised to set a new benchmark in GMP excellence, enabling simAbs and its partners to remain at the forefront of the biopharmaceutical industry.
The installation of the HVAC systems is currently underway
The integration of advanced technologies within the cleanroom will support highly regulated processes essential to the development and manufacture of bio-therapeutics.
As the project progresses, simAbs invites stakeholders and industry peers to stay tuned for further updates.The coming week will mark a major construction milestone with the completion of critical infrastructure installations.
Top image: a new GMP cleanroom facility is making progress